Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Ophthalmology Drugs & Devices market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 17.9% during the forecast period.
This report presents the market size and development trends by detailing the Ophthalmology Drugs & Devices market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Ophthalmology Drugs & Devices market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Ophthalmology Drugs & Devices industry and will help you to build a panoramic view of the industrial development.
Ophthalmology Drugs & Devices Market, By Type:
Diagnostic and monitoring devices
Surgical devices
Vision care
Drugs
Ophthalmology Drugs & Devices Market, By Application:
Cataract
Glaucoma
Refractive error
Vitreoretinal
Some of the leading players are as follows:
Santen Pharmaceutical
Essilor
Allergan
Johnson & Johnson
Hoya
Iridex
Alcon.
Ellex
Staar Surgical
Ziemer Ophthalmic Systems
Abbott
Nidek Co
Merck & Co
Pfizer
Bausch & Lomb
Roche Holding
Carl Zeiss Meditec.
Topcon
Novartis
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Ophthalmology Drugs & Devices Market: Technology Type Analysis
-
4.1 Ophthalmology Drugs & Devices Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Ophthalmology Drugs & Devices Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Diagnostic and monitoring devices
4.3.2 Surgical devices
4.3.3 Vision care
4.3.4 Drugs
5 Ophthalmology Drugs & Devices Market: Product Analysis
-
5.1 Ophthalmology Drugs & Devices Product Market Share Analysis, 2018 & 2026
-
5.2 Ophthalmology Drugs & Devices Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Ophthalmology Drugs & Devices Market: Application Analysis
-
6.1 Ophthalmology Drugs & Devices Application Market Share Analysis, 2018 & 2026
-
6.2 Ophthalmology Drugs & Devices Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Cataract
6.3.2 Glaucoma
6.3.3 Refractive error
6.3.4 Vitreoretinal
7 Ophthalmology Drugs & Devices Market: Regional Analysis
-
7.1 Ophthalmology Drugs & Devices Regional Market Share Analysis, 2018 & 2026
-
7.2 Ophthalmology Drugs & Devices Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Santen Pharmaceutical
9.1.1 Santen Pharmaceutical Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Essilor
9.2.1 Essilor Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Allergan
9.3.1 Allergan Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Johnson & Johnson
9.4.1 Johnson & Johnson Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Hoya
9.5.1 Hoya Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Iridex
9.6.1 Iridex Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Alcon.
9.7.1 Alcon. Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Ellex
9.8.1 Ellex Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Staar Surgical
9.9.1 Staar Surgical Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Ziemer Ophthalmic Systems
9.10.1 Ziemer Ophthalmic Systems Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 Abbott
9.11.1 Abbott Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
9.12 Nidek Co
9.12.1 Nidek Co Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.12.5 SWOT analysis
9.13 Merck & Co
9.13.1 Merck & Co Company overview
9.13.2 Financial performance
9.13.3 Product benchmarking
9.13.4 Strategic initiatives
9.13.5 SWOT analysis
9.14 Pfizer
9.14.1 Pfizer Company overview
9.14.2 Financial performance
9.14.3 Product benchmarking
9.14.4 Strategic initiatives
9.14.5 SWOT analysis
9.15 Bausch & Lomb
9.15.1 Bausch & Lomb Company overview
9.15.2 Financial performance
9.15.3 Product benchmarking
9.15.4 Strategic initiatives
9.15.5 SWOT analysis
9.16 Roche Holding
9.16.1 Roche Holding Company overview
9.16.2 Financial performance
9.16.3 Product benchmarking
9.16.4 Strategic initiatives
9.16.5 SWOT analysis
9.17 Carl Zeiss Meditec.
9.17.1 Carl Zeiss Meditec. Company overview
9.17.2 Financial performance
9.17.3 Product benchmarking
9.17.4 Strategic initiatives
9.17.5 SWOT analysis
9.18 Topcon
9.18.1 Topcon Company overview
9.18.2 Financial performance
9.18.3 Product benchmarking
9.18.4 Strategic initiatives
9.18.5 SWOT analysis
9.19 Novartis
9.19.1 Novartis Company overview
9.19.2 Financial performance
9.19.3 Product benchmarking
9.19.4 Strategic initiatives
9.19.5 SWOT analysis
The List of Tables and Figures (Totals 110 Figures and 132 Tables)
Figure Diagnostic and monitoring devices Ophthalmology Drugs & Devices market, 2015 - 2026 (USD Million)
Figure Surgical devices Ophthalmology Drugs & Devices market, 2015 - 2026 (USD Million)
Figure Vision care Ophthalmology Drugs & Devices market, 2015 - 2026 (USD Million)
Figure Drugs Ophthalmology Drugs & Devices market, 2015 - 2026 (USD Million)
Figure Cataract market, 2015 - 2026 (USD Million)
Figure Glaucoma market, 2015 - 2026 (USD Million)
Figure Refractive error market, 2015 - 2026 (USD Million)
Figure Vitreoretinal market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Ophthalmology Drugs & Devices market, by country, 2015 - 2026 (USD Million)
-
Table North America Ophthalmology Drugs & Devices market, by type, 2015 - 2026 (USD Million)
-
Table North America Ophthalmology Drugs & Devices market, by product, 2015 - 2026 (USD Million)
-
Table North America Ophthalmology Drugs & Devices market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Ophthalmology Drugs & Devices market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Ophthalmology Drugs & Devices market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Ophthalmology Drugs & Devices market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Ophthalmology Drugs & Devices market, by type, 2015 - 2026 (USD Million)
-
Table Canada Ophthalmology Drugs & Devices market, by product, 2015 - 2026 (USD Million)
-
Table Canada Ophthalmology Drugs & Devices market, by application, 2015 - 2026 (USD Million)
-
Table Europe Ophthalmology Drugs & Devices market, by country, 2015 - 2026 (USD Million)
-
Table Europe Ophthalmology Drugs & Devices market, by type, 2015 - 2026 (USD Million)
-
Table Europe Ophthalmology Drugs & Devices market, by product, 2015 - 2026 (USD Million)
-
Table Europe Ophthalmology Drugs & Devices market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Ophthalmology Drugs & Devices market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Ophthalmology Drugs & Devices market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Ophthalmology Drugs & Devices market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Ophthalmology Drugs & Devices market, by type, 2015 - 2026 (USD Million)
-
Table Germany Ophthalmology Drugs & Devices market, by product, 2015 - 2026 (USD Million)
-
Table Germany Ophthalmology Drugs & Devices market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Ophthalmology Drugs & Devices market, by type, 2015 - 2026 (USD Million)
-
Table France Ophthalmology Drugs & Devices market, by product, 2015 - 2026 (USD Million)
-
Table France Ophthalmology Drugs & Devices market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Ophthalmology Drugs & Devices market, by type, 2015 - 2026 (USD Million)
-
Table Italy Ophthalmology Drugs & Devices market, by product, 2015 - 2026 (USD Million)
-
Table Italy Ophthalmology Drugs & Devices market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Ophthalmology Drugs & Devices market, by type, 2015 - 2026 (USD Million)
-
Table Spain Ophthalmology Drugs & Devices market, by product, 2015 - 2026 (USD Million)
-
Table Spain Ophthalmology Drugs & Devices market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Ophthalmology Drugs & Devices market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Ophthalmology Drugs & Devices market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Ophthalmology Drugs & Devices market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Ophthalmology Drugs & Devices market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Ophthalmology Drugs & Devices market, by type, 2015 - 2026 (USD Million)
-
Table China Ophthalmology Drugs & Devices market, by product, 2015 - 2026 (USD Million)
-
Table China Ophthalmology Drugs & Devices market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Ophthalmology Drugs & Devices market, by type, 2015 - 2026 (USD Million)
-
Table Japan Ophthalmology Drugs & Devices market, by product, 2015 - 2026 (USD Million)
-
Table Japan Ophthalmology Drugs & Devices market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Ophthalmology Drugs & Devices market, by type, 2015 - 2026 (USD Million)
-
Table India Ophthalmology Drugs & Devices market, by product, 2015 - 2026 (USD Million)
-
Table India Ophthalmology Drugs & Devices market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Ophthalmology Drugs & Devices market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Ophthalmology Drugs & Devices market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Ophthalmology Drugs & Devices market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Ophthalmology Drugs & Devices market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Ophthalmology Drugs & Devices market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Ophthalmology Drugs & Devices market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Ophthalmology Drugs & Devices market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Ophthalmology Drugs & Devices market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Ophthalmology Drugs & Devices market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Ophthalmology Drugs & Devices market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Ophthalmology Drugs & Devices market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Ophthalmology Drugs & Devices market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Ophthalmology Drugs & Devices market, by application, 2015 - 2026 (USD Million)
-
Table MEA Ophthalmology Drugs & Devices market, by country, 2015 - 2026 (USD Million)
-
Table MEA Ophthalmology Drugs & Devices market, by type, 2015 - 2026 (USD Million)
-
Table MEA Ophthalmology Drugs & Devices market, by product, 2015 - 2026 (USD Million)
-
Table MEA Ophthalmology Drugs & Devices market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Ophthalmology Drugs & Devices market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Ophthalmology Drugs & Devices market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Ophthalmology Drugs & Devices market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Ophthalmology Drugs & Devices market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Ophthalmology Drugs & Devices market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Ophthalmology Drugs & Devices market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Santen Pharmaceutical Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Essilor Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Allergan Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Johnson & Johnson Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Hoya Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Iridex Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Alcon. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Ellex Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Staar Surgical Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Ziemer Ophthalmic Systems Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Abbott Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Nidek Co Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Merck & Co Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Pfizer Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Bausch & Lomb Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Roche Holding Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Carl Zeiss Meditec. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Topcon Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Novartis Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
